“…3 In contrast, the Food and Drug Administration-approved TAH produces pulsatile flow through a pneumatic driver to mitigate this challenge. 2,4 In the case of our patient, after discussion regarding the various options for permanent access and the prompt need to remove the TDC, the vascular surgery team agreed that the technical aspects of fistula creation would not differ significantly (Video 1). It was acknowledged, however, that there was an inherent degree of uncertainty.…”